Literature DB >> 15888744

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC).

E Felip1, N Pavlidis, R A Stahel.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888744     DOI： 10.1093/annonc/mdi829

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis.

Authors:  Chenguang Li; Yihua Sun; Yunjian Pan; Qifeng Wang; Shu Yang; Haiquan Chen
Journal:  Lung       Date:  2010-08-12       Impact factor: 2.584

2.  Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer.

Authors:  Joerg Stattaus; Steffen Hahn; Thomas Gauler; Wilfried Eberhardt; Stefan P Mueller; Michael Forsting; Susanne C Ladd
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

3.  Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.

Authors:  Timothy L Lochmann; Konstantinos V Floros; Mitra Naseri; Krista M Powell; Wade Cook; Ryan J March; Giovanna T Stein; Patricia Greninger; Yuki Kato Maves; Laura R Saunders; Scott J Dylla; Carlotta Costa; Sosipatros A Boikos; Joel D Leverson; Andrew J Souers; Geoffrey W Krystal; Hisashi Harada; Cyril H Benes; Anthony C Faber
Journal:  Clin Cancer Res       Date:  2017-11-08       Impact factor: 12.531

Review 4.  Treatment options for small cell lung cancer - do we have more choice?

Authors:  M Puglisi; S Dolly; A Faria; J S Myerson; S Popat; M E R O'Brien
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.